Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06290427 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K)

Study acronym: COMPAR-K
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment target: 45 to 30v2 Show 4 more changesShow less
    • Primary completion date changed from estimate of Jun 2024 to Dec 12, 2024
    • Study completion date: Dec 2024 to Jun 2025
    • Interventions: DaVinci RAPN (Device), Hugo RAS RAPN (Device), Versius® RAPN (Device) to DaVinci RAPN (Device), Hugo RAS RAPN (Device)
    • Study arms: 3 to 2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The Urology Unit of AOUI Verona proposes a clinical study aimed at a preliminary evaluation of postoperative complications specifically focused on robotic partial nephrectomy (RAPN) procedures using two currently available platforms: * DaVinci®; * Hugo®. The questions it aims to answer are: Does the estimation of the post-operative complications suggest something? Are differences (intra- and post-operative, oncological, functional, technical, and economic) among the three intervention approaches observable? Participants will be invited to join one of these two experimental group: 1. surgery with the DaVinci platform; 2. surgery with the Hugo platform.
Trial Details
NCT Number NCT06290427
Lead Sponsor Azienda Ospedaliera Universitaria Integrata Verona
Conditions
(from sponsor)		 Renal Carcinoma
Related terms Carcinoma, Renal Cell, Postoperative Complications
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov